Pharmacology of testosterone replacement therapy preparations
Shoskes, Jennifer J, Wilson, Meghan K, Spinner, Michael L
Published in Translational andrology and urology (01.12.2016)
Published in Translational andrology and urology (01.12.2016)
Get full text
Journal Article
461P Evaluation of PGN-EDODM1: FREEDOM-DM1 and FREEDOM2-DM1 clinical trials in myotonic dystrophy type 1
Larkindale, J., Shoskes, J., Garg, B., Song, G., Lonkar, P., Babcock, S., Vacca, S., Yu, S., Mellion, M.
Published in Neuromuscular disorders : NMD (01.10.2024)
Published in Neuromuscular disorders : NMD (01.10.2024)
Get full text
Journal Article
P26 CONNECT-EDO51: Trial designs to support the development of PGN-EDO51 for Duchenne Muscular dystrophy amenable to exon 51 skipping
Larkindale, J., Vacca, S., Cormier, J., Shoskes, J., Goyal, J., Holland, A., Lonkar, P., Foy, J., Mellion, M.
Published in Neuromuscular disorders : NMD (01.10.2023)
Published in Neuromuscular disorders : NMD (01.10.2023)
Get full text
Journal Article
P391 Phase 1 study to assess safety, tolerability, pharmacokinetics, and pharmacodynamics of PGN-EDODM1 in adults with myotonic dystrophy type 1 (DM1)
Shoskes, J., Larkindale, J., Cormier, J., Hand, H., Vacca, S., Lonkar, P., Holland, A., Garg, B., Foy, J., Mellion, M.
Published in Neuromuscular disorders : NMD (01.10.2023)
Published in Neuromuscular disorders : NMD (01.10.2023)
Get full text
Journal Article
P.144a Muscle ultrasound in an open-label study of losmapimod in subjects with FSHD1
Kools, J., Voermans, N., Mul, K., Jiang, J., Shoskes, J., Marshall, K., Mellion, M., van Engelen, B., Karllson, M.
Published in Neuromuscular disorders : NMD (01.10.2022)
Published in Neuromuscular disorders : NMD (01.10.2022)
Get full text
Journal Article
P.144b Feasibility of measuring functional performance of FSHD patients using wearable sensors to quantify physical activity
Kools, J., Voermans, N., Mul, K., Mellion, M., Jiang, J., Shoskes, J., Marshall, K., Jackson, D., Zhao, Y., Tarachandani, A., Figueredo, J., Eggenspieler, D., van Engelen, B.
Published in Neuromuscular disorders : NMD (01.10.2022)
Published in Neuromuscular disorders : NMD (01.10.2022)
Get full text
Journal Article
P.136 Design of Reach: Phase 3 randomized, double-blind, placebo-controlled, 48-week study of the efficacy and safety of losmapimod in FSHD
Tawil, R., Han, J., Wang, L., Vissing, J., van Engelen, B., Statland, J., Mellion, M., Shoskes, J., Morabito, C., Jiang, J., Webster, J.
Published in Neuromuscular disorders : NMD (01.10.2022)
Published in Neuromuscular disorders : NMD (01.10.2022)
Get full text
Journal Article
FSHD: EP.168 An open-label study of Losmapimod to evaluate the safe subjects with FSHD1
Kools, J., Voermans, N., Mul, K., van Engelen, B., Ronco, L., Jiang, J., Shoskes, J., Mellion, M., Marshall, K., Cadavid, D.
Published in Neuromuscular disorders : NMD (01.10.2021)
Published in Neuromuscular disorders : NMD (01.10.2021)
Get full text
Journal Article
FSHD
Kools, J., Voermans, N., Mul, K., van Engelen, B., Ronco, L., Jiang, J., Shoskes, J., Mellion, M., Marshall, K., Cadavid, D.
Published in Neuromuscular disorders : NMD (01.10.2021)
Published in Neuromuscular disorders : NMD (01.10.2021)
Get full text
Journal Article